12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Parsortix preclinical data

In vitro, the Parsortix cancer cell separation device was able to capture cultured colon cancer cells that were added to blood. The device has previously been shown to capture cultured prostate and breast cancer cells that were added to blood and CTCs in...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >